Clinical trials recruiting for Adjuvant Drug Therapy
3
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Befotertinib | 1 |
| Individual dose of tamoxifen | 1 |
| Standard adjuvant therapy of tamoxifen | 1 |
| pemetrexed /carboplatin | 1 |
Self-screener
Recruiting trials
- Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening
- Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
- The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER
Related conditions
Trials recruiting for Adjuvant Drug Therapy often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Non-small cell lung cancer 507Lung cancer 2180Geriatric Assessment 3EGFR 6Breast Cancer Early Stage Breast Cancer (Stage 1-3) 23
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Adjuvant Drug Therapy trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.